3 June, 2024HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation
22 May, 2024Noema Pharma announces first patient dosed in Phase 2a Study of NOE-115, a first-in-class investigational therapy for the treatment of vasomotor symptoms and additional symptoms associated with menopause
13 May, 2024May Health raises $25 million in Series B funding to advance development for Ovarian Rebalancing therapy